Dual-targeted STAb-T cells secreting BCMA and CD19 T cell engagers for improved control of haematological cancers
{{output}}
Despite recent advances in immunotherapy against B cell malignancies such as BCMA (B cell maturation antigen) and CD19-targeted treatments using soluble T cell-engaging (TCE) antibodies or chimeric antigen receptor T cells (CAR-T), there is still an important ... ...
